Last year of residency for radiation oncologists in France: Overview and perspectives
CONCLUSION: These results relating to the first class of junior doctors showed an overall agreement with the recommendations of the Cnec. Feedback from interns was positive. The supervision of brachytherapy and dosimetry activities, the presence alone in multidisciplinary panel remained points of vigilance.PMID:37891037 | DOI:10.1016/j.canrad.2023.08.003 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: A Larnaudie V Bourbonne M Michalet Q Laune M Delaye F Huguet D Azria R Varnier Y Ghannam Source Type: research
Survey by SFRO, SNRO and AFPPE about the evolution of the radiation therapist profession in France
CONCLUSION: This survey shows: (i) A significant involvement of radiation therapists in the task shifting; (ii) A very strong demand for career development, in particular with existing degrees or to be created degree such as advanced practice; and (iii) The need to reinforce a job satisfaction for almost the half of the respondents, linked to a workload, a mental load and some organisational difficulties.PMID:37891038 | DOI:10.1016/j.canrad.2023.07.013 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: S Boisbouvier É Bayart J Chamois P Clav ère S Corbin A De Oliveira C Geffroy-Hulot J-M Hannoun-L évi A Hasbini P Le Tallec É Monpetit J-J Santini C Bougier Source Type: research
Clinical trials that will change practices: News in palliative radiotherapy
Cancer Radiother. 2023 Oct 25:S1278-3218(23)00218-4. doi: 10.1016/j.canrad.2023.08.004. Online ahead of print.ABSTRACTPalliative radiotherapy is used to alleviate cancer-related symptoms. Symptomatic responses to palliative radiotherapy may however take several weeks, meaning that patients need to survive long enough to derive a real benefit. Oncologists can be optimistic when estimating survival for patients with advanced cancer and as a consequence some patients receiving palliative radiotherapy die before experiencing any gain. Models of patient survival have limited accuracy, particularly for predicting whether patient...
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: E Agnoux A Renan J-C Faivre Source Type: research
Last year of residency for radiation oncologists in France: Overview and perspectives
CONCLUSION: These results relating to the first class of junior doctors showed an overall agreement with the recommendations of the Cnec. Feedback from interns was positive. The supervision of brachytherapy and dosimetry activities, the presence alone in multidisciplinary panel remained points of vigilance.PMID:37891037 | DOI:10.1016/j.canrad.2023.08.003 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: A Larnaudie V Bourbonne M Michalet Q Laune M Delaye F Huguet D Azria R Varnier Y Ghannam Source Type: research
Survey by SFRO, SNRO and AFPPE about the evolution of the radiation therapist profession in France
CONCLUSION: This survey shows: (i) A significant involvement of radiation therapists in the task shifting; (ii) A very strong demand for career development, in particular with existing degrees or to be created degree such as advanced practice; and (iii) The need to reinforce a job satisfaction for almost the half of the respondents, linked to a workload, a mental load and some organisational difficulties.PMID:37891038 | DOI:10.1016/j.canrad.2023.07.013 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: S Boisbouvier É Bayart J Chamois P Clav ère S Corbin A De Oliveira C Geffroy-Hulot J-M Hannoun-L évi A Hasbini P Le Tallec É Monpetit J-J Santini C Bougier Source Type: research
Clinical trials that will change practices: News in palliative radiotherapy
Cancer Radiother. 2023 Oct 25:S1278-3218(23)00218-4. doi: 10.1016/j.canrad.2023.08.004. Online ahead of print.ABSTRACTPalliative radiotherapy is used to alleviate cancer-related symptoms. Symptomatic responses to palliative radiotherapy may however take several weeks, meaning that patients need to survive long enough to derive a real benefit. Oncologists can be optimistic when estimating survival for patients with advanced cancer and as a consequence some patients receiving palliative radiotherapy die before experiencing any gain. Models of patient survival have limited accuracy, particularly for predicting whether patient...
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: E Agnoux A Renan J-C Faivre Source Type: research
Last year of residency for radiation oncologists in France: Overview and perspectives
CONCLUSION: These results relating to the first class of junior doctors showed an overall agreement with the recommendations of the Cnec. Feedback from interns was positive. The supervision of brachytherapy and dosimetry activities, the presence alone in multidisciplinary panel remained points of vigilance.PMID:37891037 | DOI:10.1016/j.canrad.2023.08.003 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: A Larnaudie V Bourbonne M Michalet Q Laune M Delaye F Huguet D Azria R Varnier Y Ghannam Source Type: research
Survey by SFRO, SNRO and AFPPE about the evolution of the radiation therapist profession in France
CONCLUSION: This survey shows: (i) A significant involvement of radiation therapists in the task shifting; (ii) A very strong demand for career development, in particular with existing degrees or to be created degree such as advanced practice; and (iii) The need to reinforce a job satisfaction for almost the half of the respondents, linked to a workload, a mental load and some organisational difficulties.PMID:37891038 | DOI:10.1016/j.canrad.2023.07.013 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: S Boisbouvier É Bayart J Chamois P Clav ère S Corbin A De Oliveira C Geffroy-Hulot J-M Hannoun-L évi A Hasbini P Le Tallec É Monpetit J-J Santini C Bougier Source Type: research
Last year of residency for radiation oncologists in France: Overview and perspectives
CONCLUSION: These results relating to the first class of junior doctors showed an overall agreement with the recommendations of the Cnec. Feedback from interns was positive. The supervision of brachytherapy and dosimetry activities, the presence alone in multidisciplinary panel remained points of vigilance.PMID:37891037 | DOI:10.1016/j.canrad.2023.08.003 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: A Larnaudie V Bourbonne M Michalet Q Laune M Delaye F Huguet D Azria R Varnier Y Ghannam Source Type: research
Survey by SFRO, SNRO and AFPPE about the evolution of the radiation therapist profession in France
CONCLUSION: This survey shows: (i) A significant involvement of radiation therapists in the task shifting; (ii) A very strong demand for career development, in particular with existing degrees or to be created degree such as advanced practice; and (iii) The need to reinforce a job satisfaction for almost the half of the respondents, linked to a workload, a mental load and some organisational difficulties.PMID:37891038 | DOI:10.1016/j.canrad.2023.07.013 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: S Boisbouvier É Bayart J Chamois P Clav ère S Corbin A De Oliveira C Geffroy-Hulot J-M Hannoun-L évi A Hasbini P Le Tallec É Monpetit J-J Santini C Bougier Source Type: research
Clinical trials that will change practices: News in palliative radiotherapy
Cancer Radiother. 2023 Oct 25:S1278-3218(23)00218-4. doi: 10.1016/j.canrad.2023.08.004. Online ahead of print.ABSTRACTPalliative radiotherapy is used to alleviate cancer-related symptoms. Symptomatic responses to palliative radiotherapy may however take several weeks, meaning that patients need to survive long enough to derive a real benefit. Oncologists can be optimistic when estimating survival for patients with advanced cancer and as a consequence some patients receiving palliative radiotherapy die before experiencing any gain. Models of patient survival have limited accuracy, particularly for predicting whether patient...
Source: Cancer Radiotherapie - October 27, 2023 Category: Cancer & Oncology Authors: E Agnoux A Renan J-C Faivre Source Type: research
Stereotactic body radiation therapy for liver metastases in oligometastatic disease
Cancer Radiother. 2023 Oct 19:S1278-3218(23)00210-X. doi: 10.1016/j.canrad.2023.04.008. Online ahead of print.ABSTRACTOligometastatic cancers designate cancers in which the number of metastases is less than five, corresponding to a particular biological entity whose prognosis is situated between a localized and metastatic disease. The liver is one of the main sites of metastases. When patients are not suitable for surgery, stereotactic body radiotherapy provides high local control rate, although these data come mainly from retrospective studies, with no phase III study results. The need for a high therapeutic dose (biologi...
Source: Cancer Radiotherapie - October 21, 2023 Category: Cancer & Oncology Authors: N Jaksic A Modesto N Meillan A Bordron M Michalet O Riou A Lisbona F Huguet Source Type: research
Stereotactic body radiation therapy for liver metastases in oligometastatic disease
Cancer Radiother. 2023 Oct 19:S1278-3218(23)00210-X. doi: 10.1016/j.canrad.2023.04.008. Online ahead of print.ABSTRACTOligometastatic cancers designate cancers in which the number of metastases is less than five, corresponding to a particular biological entity whose prognosis is situated between a localized and metastatic disease. The liver is one of the main sites of metastases. When patients are not suitable for surgery, stereotactic body radiotherapy provides high local control rate, although these data come mainly from retrospective studies, with no phase III study results. The need for a high therapeutic dose (biologi...
Source: Cancer Radiotherapie - October 21, 2023 Category: Cancer & Oncology Authors: N Jaksic A Modesto N Meillan A Bordron M Michalet O Riou A Lisbona F Huguet Source Type: research
Stereotactic body radiation therapy for liver metastases in oligometastatic disease
Cancer Radiother. 2023 Oct 19:S1278-3218(23)00210-X. doi: 10.1016/j.canrad.2023.04.008. Online ahead of print.ABSTRACTOligometastatic cancers designate cancers in which the number of metastases is less than five, corresponding to a particular biological entity whose prognosis is situated between a localized and metastatic disease. The liver is one of the main sites of metastases. When patients are not suitable for surgery, stereotactic body radiotherapy provides high local control rate, although these data come mainly from retrospective studies, with no phase III study results. The need for a high therapeutic dose (biologi...
Source: Cancer Radiotherapie - October 21, 2023 Category: Cancer & Oncology Authors: N Jaksic A Modesto N Meillan A Bordron M Michalet O Riou A Lisbona F Huguet Source Type: research
Stereotactic body radiation therapy for liver metastases in oligometastatic disease
Cancer Radiother. 2023 Oct 19:S1278-3218(23)00210-X. doi: 10.1016/j.canrad.2023.04.008. Online ahead of print.ABSTRACTOligometastatic cancers designate cancers in which the number of metastases is less than five, corresponding to a particular biological entity whose prognosis is situated between a localized and metastatic disease. The liver is one of the main sites of metastases. When patients are not suitable for surgery, stereotactic body radiotherapy provides high local control rate, although these data come mainly from retrospective studies, with no phase III study results. The need for a high therapeutic dose (biologi...
Source: Cancer Radiotherapie - October 21, 2023 Category: Cancer & Oncology Authors: N Jaksic A Modesto N Meillan A Bordron M Michalet O Riou A Lisbona F Huguet Source Type: research
